Published in Vaccine Weekly, November 1st, 2000
"Renal cell cancer is resistant to all types of therapies," stated P. Wysocki et al. "Immunotherapy based on genetically modified tumor vaccines approaches seem to be a promising treatment of advanced stages of this cancer in patients."
Wysocki et al. presented data from their study at the 14th European Immunology Meeting, held September 23-27, 2000, in Poznan, Poland. The title of their presentation was "Application of cytokine genes in a murine model of renal cell cancer gene...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.